Skip to main content
IDYA
NASDAQ Life Sciences

IDEAYA Closes $345M Public Offering, Underwriters Fully Exercise Option

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$27.6
Mkt Cap
$2.425B
52W Low
$20.5
52W High
$39.28
52W Position info
35% above low
Off High info
30% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

IDYA sits 35% above its 52-week low of $20.5.

Summary

IDEAYA Biosciences has successfully closed its public offering, securing approximately $345.0 million in gross proceeds. This amount is higher than the initially announced $300 million, reflecting the full exercise of the underwriters' option to purchase additional shares. This significant capital infusion, following recent positive Phase 2/3 clinical trial results for darovasertib and new collaborations, substantially strengthens the company's financial position to advance its precision oncology pipeline.

At the time of this announcement, IDYA was trading at $27.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $20.50 to $39.28. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

IDYA - Latest Insights

IDYA
Nov 03, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.36
Real-time Price: $26.47 info
Change: -$4.89 (-16%) info
Market Cap: $2.561B info
IDYA
Nov 03, 2026, 6:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $31.64
Real-time Price: $26.47 info
Change: -$5.17 (-16%) info
Market Cap: $2.561B info
IDYA
Oct 19, 2026, 7:08 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.50
Real-time Price: $26.47 info
Change: -$7.03 (-21%) info
Market Cap: $2.561B info
IDYA
Aug 19, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $37.93
Real-time Price: $26.47 info
Change: -$11.46 (-30%) info
Market Cap: $2.561B info
IDYA
Aug 04, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $36.11
Real-time Price: $26.47 info
Change: -$9.64 (-27%) info
Market Cap: $2.561B info